Medical Facilities (TSE:DR) reported what management described as a “strong fourth quarter” to close out fiscal 2025, citing growth in facility service revenue, income from operations, and adjusted EBITDA for both the quarter and full year. President and CEO Jason Redman and CFO David Watson discussed results that reflected higher case volumes, favorable case and payer mixes, and ongoing efforts to improve operating efficiency.
Full-year and fourth-quarter performance
For 2025, Medical Facilities said top-line revenue increased 3.2% to $342.2 million, including 6.9% growth in the fourth quarter. Income from operations rose 6.1% to $58.0 million, and management highlighted a 20.1% increase in income from operations during Q4. Adjusted EBITDA increased 3.1% to $73.7 million for the year, including 12% growth in the quarter.
Case volumes and mix
Watson said fourth-quarter facility service revenue was $97.3 million, up 6.9% year over year, driven by the combined impact of case and payer mix along with a 2.6% increase in surgical case volumes.
By category, Watson outlined mixed trends:
- Outpatient cases increased 6.6%.
- Inpatient cases decreased 10.8%.
- Observation cases decreased 3.8%.
Pain management cases declined 13.5% in the quarter, which Watson said was mainly due to decreases at Arkansas Surgical Hospital, consistent with prior commentary from the company. He added that a new pain physician began at Arkansas Surgical Hospital in August 2025, and the company has an active recruitment campaign to attract additional pain doctors. Watson also noted that a new spine surgeon joined the referral group’s practice in September.
Expenses and profitability
Operating expenses rose $2.8 million, or 3.8%, during the quarter. Watson attributed the increase to several line items:
- Salaries and benefits: Up 2.7%, driven by annual merit increases, market wage pressures, and higher benefit costs linked to increased health plan utilization, partially offset by fewer salaried physicians and clinical staff.
- Drugs and supplies: Up 7.1%, reflecting a case mix with more orthopedic cases along with higher surgical volume.
- General and administrative expenses: Up 3.5% due to higher costs for contracted services, physician guarantees, and repairs and maintenance.
Despite the expense increases, profitability improved in Q4. Watson said income from operations increased 20.1% to $20.9 million, while adjusted EBITDA increased 12% to $24.4 million.
Capital returns, asset sales, and balance sheet
Redman emphasized shareholder returns during 2025. Following the sale of Black Hills Surgical Hospital in November 2024, the company completed a substantial issuer bid in March 2025 and, along with share repurchases under its normal course issuer bid (NCIB), returned $61.8 million to shareholders through the repurchase of more than 5.1 million shares. Management said this reduced the company’s share count by approximately 22% during the year.
The company also completed the sale of the Surgery Center of Newport Coast at year-end, receiving $1.5 million in cash proceeds for its 51% ownership interest. Redman said negotiations were underway during the period for the sale of Oklahoma Spine Hospital, which subsequently closed on Jan. 30, 2026. Medical Facilities received $46 million in cash proceeds for its 64% ownership interest.
At year-end, the company reported corporate cash of $34.2 million, which included the $1.5 million from the Newport Coast sale. Redman said the subsequent Oklahoma Spine Hospital transaction added another $46 million to corporate cash after year-end. Redman added that management continues to evaluate options “to return capital to shareholders in the most tax-efficient manner,” including continued NCIB repurchases, another substantial issuer bid, and/or a special distribution.
On the balance sheet, Watson said that at the end of December—while including Oklahoma Spine Hospital for comparison purposes—Medical Facilities had consolidated net working capital of $38.1 million and cash and cash equivalents of about $43.4 million. That compared with net working capital of $76.4 million and cash and cash equivalents of $108.5 million at the end of 2024. Watson attributed the decline in consolidated net working capital primarily to the March substantial issuer bid totaling $42.3 million and subsequent share purchases of $19.5 million under the NCIB. He also noted that the company remains free of corporate-level bank debt after fully repaying its corporate credit facility near the end of 2024.
Q&A: Oklahoma Spine process, tax disclosure timing, and policy/competition watch
During the question-and-answer session, RBC Capital Markets analyst Doug Miehm asked about the Oklahoma Spine Hospital sale process. Redman said there was not a broader process and that the transaction involved a collaborative discussion among Medical Facilities, SSM, and the company’s physician partners.
Asked about projected tax liability on the Oklahoma Spine sale, Watson said the company had not disclosed net proceeds after tax because it was still finalizing details and working with tax advisors to optimize taxes. He said the company expects to disclose that information with first-quarter results.
Miehm also asked about potential impacts from site neutrality legislation and other Medicare policy changes, as well as competition related to Sanford’s new orthopedic hospital. Redman said the company has not yet seen an impact from site neutrality implications but is watching the matter closely and will adjust strategies if needed, adding that the company’s focus is to retain as much inpatient service as possible in partnership with physicians. On Sanford’s operations, Redman said Medical Facilities has not seen an impact on Sioux Falls results, describing the market as competitive and crediting local teams for continued performance.
Redman closed the call by thanking participants and stating the company looked forward to providing further updates.
About Medical Facilities (TSE:DR)
Medical Facilities Corp owns a diverse portfolio of surgical facilities in the United States. Through its wholly-owned subsidiaries, the company owns controlling interests in four specialty hospitals and six ambulatory surgery centers. The hospitals offer a range of non-emergency surgical, imaging, diagnostic and pain management procedures, and other ancillary services. Its key revenue source is from the facility service income. The corporation’s operations are based in the United States.
